In pharma, clinical trials sometimes happen on the end consumer.
The market is full of manufacturers who cut corners on development but invest heavily in distribution and promotion. Responsible pharmaceutical companies face this problem constantly — how do you protect consumers who might be swayed by a cheap "analogue" of unknown quality?
Choose what's been proven by people and time. Atoxil has held its standard on the Ukrainian market for over 15 years.
